Political Quotes

“as we know, a vaccine against cancer is one of the most eagerly sought objectives of medical science. Preclinical studies and patient trials of several potential vaccines are under way in the United States and Europe. At the University of Alabama at Birmingham's [UAB] Comprehensive Cancer Center, at least four cancer vaccine strategies are being developed. Two of these approaches are now in clinical trials open to patients. The other two are in development in preclinical animal studies. In 1993, the National Cancer Institute [NCI] and the UAB Cancer Center entered into a cooperative agreement which provided the center with $1.5 million in support over 5 years to conduct a series of cancer vaccine trials. The UAB Cancer Center is one of 27 such centers in the Nation that meets the high standards for comprehensive designation by the NCI, and it was one of the first eight so designated in 1973. Now in its 23d year of core grant support by the NCI, the UAB center was renewed this year for core funding over the next 5 years in the range of $27 million. After meticulous review, the NCI also gave the center its highest priority rating based on program excellence. The trials currently under way at UAB include those for breast cancer, colon cancer, and melanoma. The traditional concept of vaccination is to protect against future exposure to disease.”